Comparative Analysis of National Guidelines for the Diagnosis of Tuberculosis Infection in Europe.
文献摘要
Background Diagnosis and preventive treatment of tuberculosis (TB) infection (TBI) are essential for TB prevention and elimination in the European Union/European Economic Area (EU/EEA). However, implementation of global recommendations into national guidelines and routine practice varies across the area. This study aimed to characterise current practices and assess alignment and gaps in national TBI diagnostic guidelines among European countries within the ECDC third European Reference Laboratory Network for Tuberculosis (ERLTB-Net-3). Methods A cross-sectional survey was distributed to all ERLTB-Net-3 member countries in July 2025. The survey assessed: (i) national guideline characteristics; (ii) screening indications; (iii) diagnostic practices; (iv) organisational aspects; and (v) quality assurance and monitoring. Results Of 30 ERLTB-Net-3 member countries, 24 (80%) responded. Most reported national guidelines aligned with WHO recommendations. Tuberculin skin test and interferon-gamma release assays were widely used, although testing strategies and organisational approaches varied. Few reported external quality assessment and systematic monitoring of TBI diagnosis and treatment was limited. Conclusions Despite recognition of TBI diagnosis as a priority for TB elimination in EU/EEA, substantial variation in diagnostic practices persists across the region. Greater alignment and harmonisation of diagnostic strategies, alongside strengthened quality assurance and surveillance systems, could advance TB elimination in the region.